IC-105 2 decades of Corneal Cross-Linking: Current Indications, Applications, Outcomes and complications-management; The US, FDA-approved technique and evolving technology and techniques | ASCRS
Session
IC-105 2 decades of Corneal Cross-Linking: Current Indications, Applications, Outcomes and complications-management; The US, FDA-approved technique and evolving technology and techniques
April 2024
Meeting: 2024 ASCRS Annual Meeting
Course Instructors: Alexandros John Kanellopoulos, MD; A. John Kanellopoulos, MD, ABO
This content is only available to 2024 ASCRS Annual Meeting physician registrants

To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2024 Annual Meeting registration.

Course Description
Didactic approach to the management of progressive cornea ectasia associated with keratoconus and refractive surgery.Several CXL treatment modalities will be presented, such as the single FDA approved technique in the US, but additional alternate techniques practiced internationally in order to halt ectasia,combined sometimes with a customised excimer laser ablation, intracorneal ring segments and/or phakic IOL to facilitate visual rehabilitation
      
Educational Objective
The participants will share our vast experience of 2 decades, in managing progressive keratoconus and post-LASIK, PRK and Smile ectasia with CXL. Pearls on indications, patient selection, surgical technique and complication management for safe and effective results will be presented and discussed with the participants

2024 ASCRS Annual Meeting Instructional Courses

This 1.5 hour Instructional Course was recorded at the 2024 ASCRS Annual Meeting in Boston, Massachusetts, April 5-8, 2024. 

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.